News
Vitable Health, the leading all-in-one health benefits platform redefining care for the American workforce, announced the ...
Supercede Therapeutics, Inc., a startup biotech company focused on small molecule drug development, today announced preclinical efficacy data from its lead therapeutic program to treat obesity.
Deepseek AI’s scare kicked off the year, rattling faith in the “Magnificent Seven” and the broader tech space. 💵💰Don't miss ...
The new weight loss drug which is set to give Ozempic and Mounjaro a run for their money, MariTide, is taken on a monthly ...
Boots Online Doctor has revealed the 'very common' side-effects of Mounjaro you need to know about after thousands of people ...
Many of us are dying to be skinny. We will do most anything it takes to get there, even risk our health. So, when Wegovy and ...
Novo Nordisk ends Wegovy deal with Hims over legal issues, sending the stock tumbling. What happens next? Here's a look.
Food price inflation rose to 4.7% in the four weeks to 15 June - the highest level since March - with some of the steepest ...
(Nasdaq:MODD) has shared new data highlighting the use of its insulin pump technology to deliver GLP-1 therapeutics.
The growing popularity of weight loss jabs could be affecting shopping habits in UK supermarkets, a leading research group ...
Combining bimagrumab with semaglutide caused 93% of weight loss to come from fat alone By comparison, about 72% of weight ...
A Chinese-developed GLP-1 drug is as effective as Ozempic or Zepbound, clinical trial says ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results